, Jie Zhou2, Jin Ji3, Rita R. Ellithorpe4, Steven Rosenblatt5, Antonio Jimenez6, Shigeo Ohta7, Gonzalo Ferreira8, Garth L. Nicolson91Sierra Productions Research, Irvine, CA USA
2Brunswick Laboratories, Inc., Southborough, MA USA
3PulchriBio Intl, Boston, MA USA
4Tustin Longevity Center, Tustin, CA USA
5Saint John's Health Center, Santa Monica, CA USA
6Hope4Cancer Institute, Baja California, Mexico
7Department of Neurology, Juntendo University, Graduate School of Medicine, Tokyo, Japan
8Department of Biophysicas, Laboratory of Ion Channels, School of Medicine, Universidad de la Republica, Montevideo, Uruguay
9Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA USA
Hydrogenized water is known to have protective effects on cells and tissues, mainly through its antioxidant activities. Here we examined the protective effects of a commercial source of hydrogenized water on cultured human brain cells. Hydrogenized water was able to protect brain cells from oxidative stress and glutamate toxicity. At H2 concentrations above 0.01 mM the glutathione levels increased in cultured brain cells. The level of glutathione rose from approximately 500 to approximately 850 μM at the maximum dose of hydrogenized water with an EC50 of approximately 0.030 mM. Hydrogenized water was also able to enhance the signaling pathway for oxidative stress response mediated by Nrf2 (Nuclear factor erythroid 2 like factor). Treatment of cells with hydrogenized water at concentrations above 0.01 mM H2 induced activation of Nrf2 (EC50 approximately 0.05 mM). Hydrogenized water was also able to protect brain cells against glutamate toxicity. Using a DNA damage response element, (γH2AX, to monitor the damage of glutamate toxicity we found that concentrations of H2 above 0.01 mM protected cells from glutamate damage with an EC50 of approximately 0.05 mM H2. These in vitro results demonstrated that hydrogenized water can protect brain cells against common types of damage from oxidative stress and glutamate toxicity.
| [1] | Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005; 58: 495-505.View Article PubMed |
| [2] | Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson’s disease. J Parkinsons Dis. 2013; 3(4): 461-491. PubMed PubMed |
| [3] | Schiavone S, Jaquet V, Trabace L, Krause K-H. Severe life stress and oxidative stress in the brain: from animal models to human pathology. Antioxid Redox Signal. 2013; 18(12): 1475-1490.View Article PubMed |
| [4] | Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011; 125: 376-393.View Article |
| [5] | Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med. 2008; 45: 1-17.View Article PubMed |
| [6] | Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, Maria del Razo L, Quintanilla-Vega B, Pappa A, Panayiotidis MI, Franco R. Oxidative stress, redox signaling and authophagy: cell death versus survival. Antioxid Redox Signal. 2014; 21(1): 66-85.View Article PubMed |
| [7] | Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative diseases: role of TNF. Oxid Med Cell Longev. 2015; 2015: 610813.View Article PubMed |
| [8] | Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS sources in physiological and pathological conditions. Oxid Med Cell Longev. 2016; 2016: 1245049.View Article PubMed |
| [9] | Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson’s disease. Free Radical Biol Med. 2013; 62: 13-25.View Article PubMed |
| [10] | Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983; 52: 711-760.View Article PubMed |
| [11] | Aoyama K, Nakaki T. Impaired glutathione synthesis in neurodegeneration. Int J Mol Sci. 2013; 14: 21021-21044.View Article PubMed |
| [12] | Johnson WM, Wilson-Deflosse AL, Mieyal JJ. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients. 2012; 4: 1399-1440.View Article PubMed |
| [13] | Main PAE, Angley MT, O’Doherty CE,Thomas P, Fenech M. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab. (Lond) 2012; 9: 36.View Article PubMed |
| [14] | Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53: 301-426.View Article PubMed |
| [15] | Huang Y, Li W, Su Z-Y, Kong A-NT. The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nutr Biochem. 2015; 26: 1401-1413.View Article PubMed |
| [16] | Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-Kostova AT, Hayes JD. Mechanisms of activation of the transcription factor Nrf2 by redox stressor, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radical Biol Med. 2015; 88: 108-146.View Article PubMed |
| [17] | Sandberg M, Patil J, D’Angelo B, Weber SG, Mallard C. Nrf2-regulation in brain health and disease: implication of cerebral inflammation. Neuropharmacol. 2014; 79: 298-306.View Article PubMed |
| [18] | Huang Y, Li W, Su Z-Y, Kong A-N T. The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nur Biochem. 2105; 26: 1401-1413.View Article PubMed |
| [19] | Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, et al. Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol. 2007: 66: 75-85.View Article PubMed |
| [20] | Marmiroli P, Cavaletti G. The glutamatertic neurotransmission in the central nervous system. Curr Med Chem. 2012; 19: 1269-1276.View Article PubMed |
| [21] | Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain. J Neural Transm. 2014; 121: 799-817.View Article PubMed |
| [22] | Ohta S. Molecular hydrogen as a novel antioxidant. Overview of the advantages of hydrogen for medical applications. Meth Enzymol. 2015; 555: 289-317.View Article PubMed |
| [23] | Nicolson GL, Ferreira de Mattos G, Settineri R, Costa C, Ellithorpe R, Rosenblatt S, La Valle J, Jimenez A, Ohta S. Clinical effects of hydrogen administration: from animal and human diseases to exercise medicine. Intern J Clin Med. 2016: 7: 32-76.View Article |
| [24] | Settineri R, Ji J, Luo C, Ellithorpe RR, Ferreira de Mattos G, Rosenblatt S, La Valle J, Jinenez A, Ohta S, Nicolson GL. Effects of hydrogenized water in intracellular biomarkers for antioxidants, glucose uptake, insulin signaling and SIRT1 and telomerase activity. Am J Food Nutrit. 2016; 4: 161-168. |
| [25] | Navjot S, Singh R, Sarangi U, Saxena N, Chaudhary A, Kaur G, Kaul SC, Wadhwa R. Combinations of Ashwagandha leaf extracts lprotect brain-derived cells against oxidative stress and induced differentiation. PLos One. 2015; 10: e0120554.View Article PubMed |
| [26] | Barayuga SM, Pang X, Andres MA, Panee A, Bellinger FP. Methamphetamine Decreases Levels of Glutathione Peroxidases 1 and 4 in SH-SY5Y Neuronal Cells: Protective Effects of Selenium. Neurotoxicol. 2013; 37: 240-246.View Article PubMed |
| [27] | Lee J-M, Chan K, Kan YW, Johnson JA. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. Proc Natl Acad Sci USA. 2004; 101: 9751-9756.View Article PubMed |
| [28] | R Core Team. A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria, 2017. https://www.R-project.org.View Article |
| [29] | Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain. J Neural Transm. 2014; 121: 799-817.View Article PubMed |
| [30] | Mayford M, Siegelbaum SA, Kandel ER. Synapses and memory storage. Cold Spring Har Perspect Biol. 2012; 4: a005751.View Article PubMed |
| [31] | Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002; 1: 383-386.View Article |
| [32] | Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation and function. Pharmacol Rev. 2010; 62: 405-496.View Article PubMed |
| [33] | Lewerenz J, Maher P. Chronic glutamate toxicity in neurodegenerative diseases-What is the evidence? Front Neurosci. 2015; 9: 469.View Article PubMed |
| [34] | Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD. Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J Neural Transm. 1997; 104: 661-667.View Article PubMed |
| [35] | Mischley LK, Conley KE, Shankland EG, Kavanagy TJ, Rosenfeld ME, Duda JE, White CC, Wilbur TK, De La Torre P, Padowski JM. Central nervous system uptake of intranasal glutathione in Parkinson’s disease. NPJ Parkinson's Dis. 2016; 2: 16002.View Article PubMed |
| [36] | Sies H, Berndt C, Jones DP. Oxidative Stress. Annu Rev Biochem. 2017; 86: 715-748.View Article PubMed |
| [37] | Liu Y, Hyde AS, Simpson MA, Barycki JJ. Emerging regulatory paradigms in glutathione metabolism. Adv Cancer Res. 2014; 122: 69-101.View Article PubMed |
| [38] | Currais A, Maher P. Functional consequences of age-dependent changes in glutathione status in the brain. Antioxid Redox Signal. 2013; 19: 813-822.View Article PubMed |
| [39] | Towsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003; 22: 7369-7375.View Article PubMed |
| [40] | Suryakant KN, Khatri R, Jaiswal AK. Regulation of Nrf2 – An update. Free Radic Biol Med. 2014; 66.View Article |
| [41] | Gao B, Doan A, Hybertson BM. The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders. Clin Pharmacol. 2014; 6: 19-39. PubMed PubMed |
| [42] | Su Z-Y, Shu L, Khor TO, Lee JH, Fuentes F, Kong A-N T. A perspective on dietary phytochemicals and cancer prevention: oxidative stress, Nrf2 and epigenomics. Top Curr Chem. 2013; 329: 133-162.View Article PubMed |
| [43] | Ma Q, He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev. 2012; 64: 1055-1081.View Article PubMed |
| [44] | Loboda A, Damulewicz, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016; 73: 3221-3247.View Article PubMed |
| [45] | Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015; 88: 314-336.View Article PubMed |